FDA Approves TRAZODONE HYDROCHLORIDE — Apotex Corp

# FDA Approves Generic Trazodone Hydrochloride ANDA for Apotex Corp Apotex Corp received FDA approval for its generic trazodone hydrochloride oral formulation (ANDA071258) on March 25, 1987, positioning the Canadian pharmaceutical manufacturer to compete in the antidepressant market as the branded product's patent exclusivity begins to erode. The approval enables Apotex to capture market share in the growing generic depression treatment segment, leveraging lower-cost manufacturing to compete against established branded alternatives.